Analysis of novel cardiac biomarkers in diagnosis of decompensated heart failure

26 August 2022 (08:00 - 19:30)

Organised by:

Sign in to view the resources

Sign in for access options

About the speaker

Doctor Rudin Pistulli

University Hospital of Munster, Munster (Germany)

6 More presentations in this session

Presentation thumbnail

Impact of inflammatory phenotype on prognostic discrimination for the novel biomarker cellular communication network factor 1 (CCN1) in patients with dilated cardiomyopathy

Doctor R. Klingenberg (Frankfurt, DE)

Abstract Slides

Presentation thumbnail

NT-proBNP is superior to novel plasma biomarkers for predicting adverse outcome in arrhythmogenic right ventricular cardiomyopathy

Doctor O. Wozniak (Warsaw, PL)

Abstract Slides

Presentation thumbnail

Aptamer proteomics for biomarker discovery in heart failure with reduced ejection fraction

Doctor J. Cunningham (Boston, US)

Abstract Slides

Presentation thumbnail

Vascular endothelial factor C and D in patients with heart failure with preserved, mildly reduced, and reduced ejection fraction: the PREHOSP-CHF Study

Doctor M. Iguchi (Kyoto, JP) Professor K. Hasegawa (Kyoto, JP)

Abstract Slides

Presentation thumbnail

Heart failure is associated with low circulating levels of secreted frizzled receptor protein 5 (Sfrp5).

Mr C. Kelly (Newcastle, AU)

Abstract Slides

Access the full session

Session thumbnail

Biomarkers for heart failure 1

The Event

Event poster

ESC Congress 2022

26 August - 29 August 2022

You may be interested in

Congress Presentation

The role of a multimarker panel in the diagnosis and prognosis of patients with acute heart failure

Congress Session

From genetic signatures to clinical implications

Congress Presentation

Growth differentiation factor 15 and absorption loss as new biomarkers of heart failure decompensation

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources